BioHealth News

BioHealth Capital Region Achieves Top 3 Ranking: A Triumph of Collaboration and Innovation

BioHealth Capital Region Achieves Top 3 Ranking: A Triumph of Collaboration and Innovation

In 2016, during the Annual BioHealth Capital Region Forum at MedImmune/AstraZeneca in Gaithersburg, Maryland, an ambitious goal was set: to make the BioHealth Capital…

Read More
Record Growth in Research Funding and Startups: Highlights from the 2022 AUTM Licensing Survey

Record Growth in Research Funding and Startups: Highlights from the 2022 AUTM Licensing Survey

The Association of University Technology Managers (AUTM) has released its annual Licensing Survey for 2022, revealing promising trends in technology transfer across the United…

Read More
MaxCyte Signs Strategic Platform License with Prime Medicine to Advance Next-Generation Gene Editing Therapies for Patients

MaxCyte Signs Strategic Platform License with Prime Medicine to Advance Next-Generation Gene Editing Therapies for Patients

Prime Medicine to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to advance their innovative Prime Editing technology and develop a new class of…

Read More
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola

Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola

GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development…

Read More
Charlottesville’s RIVANNA receives $30.5 million from BARDA to advance the Accuro XV musculoskeletal imaging system

Charlottesville’s RIVANNA receives $30.5 million from BARDA to advance the Accuro XV musculoskeletal imaging system

CHARLOTTESVILLE, VA, JULY 26, 2023 — RIVANNA®, developers of imaging-based medical solutions, announced that they have received funding totaling $30.5 million over 39 months…

Read More
miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases

miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases

After the race to find a COVID-19 vaccine, researchers set off to explore other disease areas with similar RNA vehicles. miRecule, a US biotechnology…

Read More
Virginia Workforce Award to AMPEL BioSolutions

Virginia Workforce Award to AMPEL BioSolutions

Virginia officials recognized AMPEL BioSolutions today for their dedication to identifying, training, and retaining STEM-trained workers, especially in the area of precision medicine. The…

Read More
Baltimore’s AsclepiX Therapeutics Raises $10 Million to Advance Clinical Study

Baltimore’s AsclepiX Therapeutics Raises $10 Million to Advance Clinical Study

Perceptive Advisors leads round to execute study in patients with wet age-related macular degeneration (wet AMD) BALTIMORE, MD, July 26, 2023– AsclepiX Therapeutics, Inc., a…

Read More
Virginia’s Solar Biotech Acquires VC-Backed Digital Biotech Noblegen

Virginia’s Solar Biotech Acquires VC-Backed Digital Biotech Noblegen

NORTON, Va. and PETERBOROUGH, ON, July 25, 2023 /PRNewswire/ - Solar Biotech Inc., a Norton, Virginia-based provider of complete sustainable and scalable biomanufacturing solutions, continues to build out its vertically…

Read More
United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the United States Court of…

Read More
Fierce Biotech: Previous Crab Trap Winner Galen Robotics nets FDA de novo clearance for ENT surgery helper

Fierce Biotech: Previous Crab Trap Winner Galen Robotics nets FDA de novo clearance for ENT surgery helper

Galen Robotics has claimed a de novo device clearance from the FDA for its digital surgical assistant, designed to provide a helping hand during…

Read More
Apply Now for the 6th Annual BioHealth Capital Region Investor Conference: Uniting Visionary Entrepreneurs and Pioneering Investors for Transformative Funding

Apply Now for the 6th Annual BioHealth Capital Region Investor Conference: Uniting Visionary Entrepreneurs and Pioneering Investors for Transformative Funding

The 6th Annual BioHealth Capital Region Investor Conference is just around the corner! Taking place on September 21st, 2023, at the US Pharmacopeia, this…

Read More
FinaBio’s Andrew Lees Wins Derek Horton Award in Industrial Carbohydrate Chemistry

FinaBio’s Andrew Lees Wins Derek Horton Award in Industrial Carbohydrate Chemistry

Andrew Lees has received The Derek Horton Award in Industrial Carbohydrate Chemistry for outstanding contributions to industrial carbohydrate chemistry. The Derek Horton Award in…

Read More
Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Emergent has been delivering CYFENDUS™ vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use Authorization status, and will continue to…

Read More
TEDCO Announces FY24 Board of Directors

TEDCO Announces FY24 Board of Directors

Talented, diverse, and experienced leaders tapped to support Maryland’s economic engine for technology companies   COLUMBIA, Md. (July 20, 2023) – TEDCO, Maryland’s economic…

Read More